IDERA PHARMACEUTICALS, INC.·4

Jan 7, 8:29 PM ET

YINGLING JONATHAN MICHAEL 4

4 · IDERA PHARMACEUTICALS, INC. · Filed Jan 7, 2019

Insider Transaction Report

Form 4
Period: 2019-01-03
YINGLING JONATHAN MICHAEL
SVP of Early Development
Transactions
  • Award

    Common Stock

    2019-01-03+18,10018,100 total
  • Award

    Stock Option (Right to Buy)

    2019-01-03+45,50045,500 total
    Exercise: $3.14Exp: 2029-01-03Common Stock (45,500 underlying)
Footnotes (2)
  • [F1]Represents a restricted stock unit ("RSU") award granted under the Issuer's 2013 Stock Incentive Plan. Each RSU represents a right to receive one share of Issuer common stock. The RSU award vests over a four-year period commencing on January 3, 2019. Twenty-five percent (25%) of the shares subject to the RSU award shall vest on each one-year anniversary of the grant date of the award.
  • [F2]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 3, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 3, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -